Vav regulates peptide-specific apoptosis in thymocytes

Citation
Yy. Kong et al., Vav regulates peptide-specific apoptosis in thymocytes, J EXP MED, 188(11), 1998, pp. 2099-2111
Citations number
83
Categorie Soggetti
Medical Research General Topics
Journal title
JOURNAL OF EXPERIMENTAL MEDICINE
ISSN journal
00221007 → ACNP
Volume
188
Issue
11
Year of publication
1998
Pages
2099 - 2111
Database
ISI
SICI code
0022-1007(199812)188:11<2099:VRPAIT>2.0.ZU;2-2
Abstract
The protooncogene Vav functions as a GDP/GTP exchange factor (GEF) for Rho- like small GTPases involved in cytoskeletal reorganization and cytokine pro duction in T cells. Gene-targeted mice lacking Vav have a severe defect in positive and negative selection of T cell antigen receptor transgenic thymo cytes in vivo, and vav(-/-) thymocytes are completely resistant to peptide- specific and anti-CD3/anti-CD28-mediated apoptosis. Vav acts upstream of mi te chondrial pore opening and caspase activation. Biochemically, Vav regula tes peptide-specific Ca2+ mobilization and actin polymerization. Peptide-sp ecific cell death was blocked both by cytochalasin D inhibition of actin po lymerization and by inhibition of protein kinase C (PKC). Activation of PKC with phorbol ester restored peptide-specific apoptosis in vav(-/-) thymocy tes. Vav was found to bind constitutively to PKC-theta in thymocytes. Our r esults indicate that peptide-triggered thymocyte apoptosis is mediated via Vav activation, changes in the actin cytoskeleton, and subsequent activatio n of a PKC isoform.